The role of progesterone in prevention of preterm birth

International Journal of Women's Health

Volumn 1, Issue 1, 2009, Pages 73-84

  Dodd, Jodie M ^a   Crowther, Caroline A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Preterm birth; Progesterone; Randomized trial; Systematic review

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; HYDROXYPROGESTERONE CAPROATE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYOSIN LIGHT CHAIN; PLACEBO; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROSTAGLANDIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST; COUGHING; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG SCREENING; EVENING DOSAGE; FEMALE; HIGH RISK PREGNANCY; HUMAN; INFLAMMATION; LABOR ONSET; NAUSEA; NONHUMAN; PERINATAL DEATH; PREGNANCY; PREMATURE LABOR; PREMATURITY; PROGESTERONE BLOOD LEVEL; PROPHYLAXIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BINDING; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW;

EID: 77953428838     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/ijwh.s4730     Document Type: Review

References (139)

1. World Health Organization (WHO): Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO October 14 1976. Acta Obstet Gynecol Scand. 1977;56:247-253.
2. Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol. 2004;104:78-87.
3. Steer P. The epidemiology of preterm labour. BJOG. 2005; 112(Suppl 1):1-3.
4. Wen SW, Smith G, Yang Q, Walker M. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med. 2004;9(6): 429-435.
5. Kuehn BM. Groups take aim at US preterm birth rate. JAMA. 2006;296:2907-2908.
6. Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ. 2006;332:937-939.
7. Tracy SK, Tracy MB, Dean J, Laws PJ, Sullivan EA. Spontaneous preterm birth of liveborn infants in women at low risk in Australia over 10 years: a population-based study. BJOG. 2007;114:731-735.
8. Laws PJ, Graylon N, Sullivan EA. Australia's mothers and babies 2004. Sydney: Australian Institute of Health and Welfare, National Perinatal Statistics Unit; 2006.
9. Canadian Perinatal Health Report, 2003.
10. Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J, Group ftPS. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. BJOG. 2006;113:528-535.
11. Smith GC, Shah I, Pell JP, Crossley JA, Dobbie R. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health. 2007;97:157-162.
12. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: Final Data for 2004. Natl Vital Stat Rep. 2006;55:1-140.
13. Burguet A, Kaminski M, Abraham-Lerat L, Schaal JP, Cambonie G, Fresson J, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the Epipage study. BJOG. 2004;111:258-265.
14. European community collaborative study of outcome of pregnancy between 22 and 28 weeks gestation. Working group on the very low birthweight infant. Lancet. 1990;336:782-784.
15. Chan K, Ohlsson A, Synnes A, Lee DSC, Chien L, Lee SK, et al. Survival, morbidity, and resource use of infants of 25 weeks gestational age or less. Am J Obstet Gynecol. 2001;185:220-226.
16. Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and infant health study group of the Canadian perinatal surveillance system. JAMA. 2000;284:843-849.
17. Mattison DR, Damus K, Fiore E, Petrini J, Alter C. Preterm delivery: a public health perspective. Paediatric and Perinatal Epidemiology. 2001;15(Suppl. 2):7-16.
18. Lefebvre F, Glorieux J, St. Laurent-Gagnon T. Neonatal survival and disability rate at age 18 months for infants born between 23 and 28 weeks of gestation. Am J Obstet Gynecol.1996;174:833-838.
19. Donoghue D, Bawden K, Cartwright D, Darlow B, Henderson-Smart D, Lancaster P. The report of the Australian and New Zealand Neonatal Network, 2000. Sydney: ANZNN; 2002.
20. O'Shea TM, Klinepeter KL, Goldstein DJ, Jackson BW, Dillard RG. Survival and developmental disability in infants with birthweights of 501 to 800 g, born between 1979 and 1994. Pediatrics. 1997;100: 982-986.
21. Hack M, Friedman H, Fanaroff AA. Outcome of extremely low birthweight infants. Pediatrics. 1996;98:931-937.
22. Allen MC, Donohue PK, Dusman AE. The limit of viability - neonatal outcome of infants born at 22 to 25 weeks gestation. N Engl J Med. 1993;329:1597-1601.
23. Kilpatrick SJ, Schleuter MA, Piecuch RE, Leonard CH, Rogido M, Sola A. Outcome of infants born at 24-26 weeks gestation: I. survival and cost. Obstet Gynecol. 1997;90:803-808.
24. Elder DE, Hagan R, Evans SF, Benninger HR, French NP. Hospital admissions in the first year of life in very preterm infants. J Paediatr Child Health. 1999;35(2):145-150.
25. Petrou S, Mehta Z, Hockley C, Cook-Mozaffari P, Henderson J, Goldacre M. The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics. 2003;112:1290-1297.
26. Hack M, Fanaroff A. Outcome of extremely low birthweight and gestational age in the 1990s. Early Hum Dev. 1999;53:193-218.
27. Wood N, Marlow N, Costeloe K, Gibson A, Wilkinson A. Neurologic and developmental disability after extremely preterm birth. N Engl J Med. 2000;343:378-384.
28. Stanley F. Survival and cerebral palsy in low birthweight infants: implications for perinatal care. Paediatr Perinat Epidemiol. 1992; 6:298-310.
29. Saigal S, Szatmari P, Rosenbaum P, Campbell D, King S. Cognitive abilities and school performance of extremely low birthweight children and matched term control children at age 8 years: a regional study. J Pediatr. 1991;118:751-760.
30. Saigal S, Hoult L, Streiner D, Stoskopf BL, Rosenbaum P. School difficulties at adolescence in a regional cohort of children who were extremely low birth weight. Pediatrics. 2000;105:325-331.
31. Buck G, Msall M, Schisterman E, Lyon N, Rogers B. Extreme prematurity and school outcomes. Paediatr Perinat Epidemiol. 2000; 14:324-331.
32. Botting N, Powls A, Cooke RWI, Marlow N. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at age 12 years. J Child Psychol Psychiatry. 1997;38:931-941.
33. Hall A, McLeod A, Counsell C, Thomson L, Mutch L. School attainment, cognitive ability and motor function in a total Scottish very low birthweight population at 8 years - a controlled study. Dev Med Child Neurol. 1995;37:1037-1050.
34. Horwood LJ, Mogridge N, Darlow B. Cognitive, educational and behavioural outcomes at 7-8 years in a national very low birthweight cohort. Arch Dis Child Fetal Neonatal Ed. 1998;79: F12-F20.
35. The Scottish low birth-weight study: II language attainment, cognitive status and behavioural impairment at 4 years. Arch Dis Child. 1992;67:682-689.
36. Botting N, Powls A, Cooke RWI, Marlow N. Cognitive and educational outcome of very low birthweight children in early adolescence. Dev Med Child Neurol. 1998;40:652-660.
37. Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, Klein N. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med. 2002;346:149-157.
38. Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, Andreias L, et al. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA. 2005;294:318-325.
39. Morrison JC. Preterm birth: a puzzle worth solving. Obstet Gynecol. 1990;76:5S-12S.
40. Gilbert WM, Nesbitt TS, Danielsen B. The cost of prematurity: Quantification by gestational age and birth weight. Obstet Gynecol. 2003;102:488-492.
41. Clements KM, Barfield WD, Femi Ayadi M, Wilber N. Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics. 2007;119:e866-e874.
42. McCormick CM. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985;312:82-90.
43. Lang JM, Lieberman E, Cohen A. A comparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology. 1996;7:369-376.
44. Scholl TO, Hediger ML, Belsky DH. Prenatal care and maternal health during adolescent pregnancy: A review and meta-analysis. J Adolesc Health. 1994;15:444-456.
45. Prysak M, Lorenz RP, Kisly A. Pregnancy outcome in nulliparous women 35 years and older. Obstet Gynecol. 1995;85:65-70.
46. Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. Am J Obstet Gynecol. 1979;135:1086-1103.
47. Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates and factors associated with recurrence of preterm delivery. JAMA. 2000;283:1591-1596.
48. Bloom SL, Yost NP, McIntire DD, Leveno KJ. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98: 379-385.
49. Berkowitz G, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev. 1993;88:233-238.
50. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339:313-320.
51. Kaminski M, Goujard J, Rumeau-Rouquette C. Prediction of low birthweight and prematurity by a multiple regression analysis with maternal characteristics known since the beginning of the pregnancy. Int J Epidemiol. 1973;2:195-204.
52. Papiernik E, Kaminski M. Multifactorial study of the risk of prematurity at 32 weeks of gestation: a study of the frequency of 30 predictive characteristics. J Perinat Med. 1974;2:30-36.
53. Robinson JN, Regan JA, Norwitz ER. The epidemiology of preterm labour. Semin Perinatol. 2001;25:204-214.
54. Kistka ZAF, Palomar L, Lee KA, Boslaugh SE, Wangler MF, Cole FS, et al. Racial disparity in the frequency of recurrence of preterm birth. Am J Obstet Gynecol. 2007;196:131.e1-131.e6.
55. Petrini J, Callaghan W, Klebanoff M, Green N, Lackritz E, Howse J, et al. Estimated effect of 17 alpha hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol. 2005;105: 267-272.
56. Mercer BM, Goldenberg RL, Moawad AH, Meis PJ, Iams JD, Das AF, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcomes. Am J Obstet Gynecol. 1999;181(5 part 1):1216-1221.
57. Carr-Hill RA, Hall MH. The repitition of spontaneous preterm labour. BJOG. 1985;92:921-928.
58. Kliegman RM, Rottman CJ, Behrman RE. Strategies for the prevention of low birthweight. Am J Obstet Gynecol. 1990;162:1073-1083.
59. Hewitt BC, Newnham JP. A review of the obstetric and medical complications leading to the delivery of very low birth weight infants. Med J Aust. 1988;149:234-237.
60. McLaughlin KJ, Crowther CA, Vigneswaran P, Hancock E, Willson K. Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks? Aust N Z J Obstet Gynaecol. 2002;42(4):353-357.
61. Moutquin JM. Socio-economic and psychosocial factors in the management and prevention of preterm labour. BJOG. 2003; 110(Suppl 20):56-60.
62. Challis JR, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000;21: 514-550.
63. Challis JR, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, et al. Prostaglandins and mechanisms of preterm birth. Reproduction. 2002;124:1-17.
64. Lopez Bernal A. Mechanisms of labour - biochemical aspects. Br J Obstet Gynaecol. 2003;110(Suppl 20):39-45.
65. Astle S, Slater DM, Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol. 2003;108:177-181.
66. Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregancy. Endocrine Rev. 1995;16:608-648.
67. Pieber D, Allport VC, Hills F, Johnson M, Bennett PR. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod. 2001;7:875-879.
68. Grazzini E, Guillon G, Mouillac B, Zingg HH. inhibition of oxytocin receptor function by direct binding of progesterone. Nature. 1998;392:509-512.
69. deZiegler D, Bulletti C, Fanchin R, Epiney M, Brioschi PA. Contractility of the nonpregnant uterus: the follicular phase. Ann NY Acad Sci. 2001;943:172-184.
70. Csapo AI. Progesterone "block". Am J Anat. 1956;98:273-292.
71. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig. 2004;11: 193-202.
72. Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regul Pept. 2002;108:159-164.
73. Haluska GJ, Wells TR, Hirst JJ, Brenner RM, Sadowsky DW, Novy MJ. Progesterone receptor localization and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition. J Soc Gynecol Investig. 2002;9:125-136.
74. Condon JC, Jeyasuria P, Faust JM, Wilson JW, Mendelson CR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize pregesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A. 2003;100:9518-9523.
75. Jenkin G, Thorburn GD. Inhibition of progesterone secretion by a 3 beta hydroxysteroid dehydrogenase inhibitor in late pregnant sheep. Can J Physiol Pharmacol. 1985;63(2):136-142.
76. Block BS, Liggins GC, Creasy RK. Preterm delivery is not predicted by serial plasma estradiol or progesterone concentration measurements. Am J Obstet Gynecol. 1984;150:716-722.
77. Smit DA, Essed GG, deHaan J. Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour. Gynecol Obstet Invest. 1984;18(5):252-263.
78. Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann N Y Acad Sci. 1991;662:355-375.
79. McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy (Cochrane Review). The Cochrane Library. 2005(Issue 1 Cichester UK, John Wiley and Sons Ltd).
80. Gibb W, Challis JR. Mechanisms of term and preterm birth. J Obstet Gynaecol Can. 2002;24(11):874-883.
81. Smith R, Mesiano S, Nicholson R, Zakar T, Chan E, Bisits A, et al. Control of the length of gestation: lessons from women. In: Critchley H, Bennett P, Thornton S, editors. Preterm Birth. London: RCOG Publications; 2004.
82. Elovitz M, Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol. 2004;190:693-701.
83. Elovitz MA, Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol. 2006;195:1004-1010.
84. Elovitz MA, Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation? Am J Obstet Gynecol. 2005;193(3 Part 2):1149-1155.
85. Shields AD, Wright J, Paonessa DJ, Gotkin J, Howard BC, Hoeldtke NJ, et al. Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol. 2005;193 (3 Part 2):1144-1148.
86. Gotkin JL, Celver J, McNutt P, Shields AD, Howard BC, Paonessa DJ, et al. Progesterone reduces lipopolysaccharide induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells. Am J Obstet Gynecol. 2006;195: 1015-1019.
87. Abate A, Brigandi A, Costabile L, Abate FG, Balzano E, Perino M. 17-alpha-hydroxyprogesterone caproate and natural progesterone in assisted reproduction: a comparative study. Clin Exp Obstet Gynecol. 1997;24(4):190-192.
88. Levy T, Gurevitch S, Bar-Hava I, Ashkenazi J, Magazanik A, Homburg R, et al. Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet. Hum Reprod. 1999;14: 606-610.
89. Penzias AS. Luteal phase support. Fertil Steril. 2002;77:318-323.
90. Tavaniotou A, Smitz J, Bourgain C, Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update. 2000;6:139-148.
91. Cicinelli E, Savino F, Cagnazzo I, Scorcia P. Comparative study of progesterone plasma levels after nasal spray and intramuscular administration of natural progesterone in menopausal women. Gynecol Obstet Invest. 1993;35(3):172-174.
92. Mircioio C, Perju A, Neagu A, Griu E, Calin G, Miron DS. Pharmacokinetics of progesterone in postmenopausal women: 1. pharmacokinetics following intravaginal administration. Eur J Drug Metab Pharmacokinet. 1998;23:391-396.
93. Onsrud M, Paus E, Haug E, Kjorstad K. Intramuscular administration of hydroxyprogesterone caproate in patients with endometrial carcinoma. Pharmacokinetics and effects on adrenal function. Acta Obstet Gynecol Scand. 1985;64:519-523.
94. Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol. 1995;85:141-149.
95. Schardein JL. Congenital abnormalities and hormones during pregnancy: a clinical reveiw. Teratology. 1980;22:251-270.
96. Crossley KJ, Nicol MB, Hirst JJ, Walker D, Thorburn GD. Suppression of arousal by progesterone in fetal sheep. Reprod Fertil Dev. 1997;9:767-773.
97. Nicol MB, Hirst JJ, Walker D. Effects of pregnanolone on behavioural parameters and the responses to GABA(A) receptor antagonists in the late gestation fetal sheep. Neuropharmacology. 1999;38:49-63.
98. Nicol MB, Hirst JJ, Walker D, Thorburn GD. Effect of alteration of maternal plasma progesterone concentrations on fetal behavioural state suring late gestation. J Endocrinol. 1997;152:379-386.
99. Dalton K. Antenatal progesterone and intelligence. Br J Psychiatry. 1968;114:1377-1382.
100. Dalton K. Prenatal progesterone and educational attainments. Br J Psychiatry. 1976;129:438-442.
101. Kester P, Green R, Finch SJ, Williams K. Prenatal "female hormone" administration in psychosexual development in males. Psychoneuroendocrinology. 1980;5:269-285.
102. Reinisch JM, Karow WG. Prenatal exposure to synthetic progestins and estrogens: effects on human development. Arch Sex Behav. 1977;6:257-288.
103. LeVine L. Habitual abortion. A controlled clinical study of progestational therapy. West J Surg. 1964;72:30-36.
104. da Fonseca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419-424.
105. Meis PJ, Klebanoff M, Thom E, Mitchell Pea. Prevention of recurrent preterm delivery by 17-alpha hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379-2385.
106. Coomarasamy A, Thangaratinam S, Gee H, Khan KS. Progesterone for the prevention of preterm birth: a critical evaluation of evidence. Eur J Obstet Gynecol Reprod Biol. 2006;129:111-118.
107. Dodd JM, Crowther CA, Cincotta R, Flenady VJ, Robinson JS. Progesterone supplementation for the prevention of preterm birth: a systematic review. Acta Obstet Gynecol Scand. 2005;84:526-533.
108. Dodd JM, Flenady VJ, Cincotta R, Crowther CA. Progesterone for the prevention of preterm birth: A systematic review. Obstet Gynecol. 2008;112:127-134.
109. Dodd JM, Flenady VJ, Cincotta R, Crowther CA. Prenatal progesterone for prevention of preterm birth. Cochrane Database Syst Rev. 2009. In press.
110. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2006;194:1234-1242.
111. Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2005;105:273-279.
112. How HY, Sibai BM. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag. 2009;5:55-64.
113. Jayasooriva GS, Lamont RF. The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth. Expert Opin Pharmacother. 2009;10(6):1007-1016.
114. O'Brien JM, Lewis DF. Progestins for the prevention of spontaneous preterm birth: review and implications of recent studies. J Reprod Med. 2009;54(2):73-87.
115. Tita AT, Rouse DJ. Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol. 2009;200:219-224.
116. Northen AT, Norman GS, Anderson K, Moseley L, Divito M, Cotroneo M, et al. Follow-up of children exposed in utero to 17 alphahydroxyprogesterone caproate compared with placebo. Obstet Gynecol. 2007;110:865-872.
117. O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized double blind placebo controlled trial. Ultrasound Obstet Gynecol. 2007;30:687-696.
118. Rozenberg P. Efficacy of 17 alpha-hydroxyprogesterone caproate for the prevention of preterm delivery. Available at http://controlledtrials.com. Accessed 2007.
119. Crowther CA, Dodd JM, McPhee AJ, Flenady V. Australasian Collaborative Trial of Vaginal Progesterone Therapy (The PROGRESS Trial) Available at http://controlledtrials.com. Accessed 2007.
120. Perlitz Y. Prevention of recurrent preterm delivery by a natural progesterone agent. Available at http://controlledtrials.com. Accessed 2007.
121. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357:462-469.
122. Grobman W. RCT of progesterone to prevent preterm birth in nulliparous women with a short cervix. Available at http://controlledtrials.com. Accessed 2007.
123. Hartikainen-Sorri AL, Kauppila A, Tuimala R. Inefficacy of 17 alpha hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol. 1980;56:692-695.
124. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, et al. A trial of 17 Alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;357: 454-461.
125. Bruinse HW. 17 alpha hydroxyprogesterone in multiple pregnancies to prevent handicapped infants (The AMPHIA Study). Available at http://www.controlledtrials.com. Accessed 2007.
126. Maurel K, Combs A. 17OHP for reduction of neonatal morbidity due to preterm birth (PTB) in twin and triplet pregnancies. Available at http://controlledtrials.com. Accessed 2007.
127. Nassar A. Prevention of preterm delivery in twin pregnancies by 17 alpha hydroxyprogesterone caproate. Available at http://controlledtrials.com. Accessed 2007.
128. Norman J. Double blind randomised placebo controlled trial of progesterone for the prevention of preterm birth. Available at http://controlledtrials.com. Accessed 2007.
129. Rode L. The PREDICT study. Available at http://controlledtrials.com. Accessed 2007.
130. Serra V. Natural progesterone and preterm birth in twins. Available at http://controlledtrials.com. Accessed 2007.
131. Wood S. Vaginal progesterone versus placebo in multiple pregnancy. Available at http://controlledtrials.com. Accessed 2007.
132. Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial. Aust N Z J Obstet Gynaecol. 2008;48:58-63.
133. Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha- hydroxyprogesterone caproate. Am J Obstet Gynecol. 2007;196:453e1-453e4.
134. Matrinez de Tajada B. Vaginal progesterone to prevent preterm delivery in women with preterm labor. Available at http://controlledtrials.com. Accessed 2007.
135. Greene MF. Progesterone and preterm delivery - deja vu all over again. N Engl J Med. 2003;348:2453-2455.
136. Iams JD. Supplemental progesterone to prevent preterm birth. Am J Obstet Gynecol. 2003;188(2):303.
137. Johnson JWC, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17 alpha hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med. 1975;293:675-680.
138. Papiernik-Berkhauer E. Etude en double aveugle d'un medicament prevenant la survenue prematuree de l'accouchement chez les femmes a risque eleve d'accouchement premature. Edition Schering Serie IV. 1970;3:65-68.
139. Hauth JC, Gilstrap LC, Brekken AL, Hauth JM. The effect of 17 alpha hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol. 1983;146:187-190.